Subtyping-Directed Precision Treatment Refines Traditional One-Size-Fits-All Therapy for HR+/HER2- Breast Cancer.

Journal:
Cancer Research
Published:
DOI:
10.1158/0008-5472.can-24-5002
Affiliations:
3
Authors:
12
Go to article
Institutions Authors Share
Fudan University Shanghai Cancer Center (FUSCC), China
10.000000
10.000000
 0.83
Hospital and Cancer Center, CQU, China
2.000000
 0.17
Interested in Oncology and Carcinogenesis?